Tonix Pharmaceuticals Holding Corp. will report its second quarter 2026 financial results and operational highlights on Monday, August 10, 2026, at 8:30 a.m. Eastern Time. The company will host a conference call and webcast, with registration links provided in the announcement. A replay will be available under "IR Events" in the Investors section of the company's website. Tonix is a fully integrated, commercial-stage biotechnology company focused on central nervous system disorders, infectious diseases, immunology conditions, and rare diseases.
Tonix Pharmaceuticals Holding CorpThe article only announces the date of the Q2 2026 earnings report; no actual results or guidance are provided, so the impact is unclear.